LTS - Lohmann Therapy Systems
Philip Prasser is a seasoned quality assurance professional with extensive experience in the pharmaceutical and diagnostics industries. Currently serving as a QA Technical Specialist at LTS - Lohmann Therapy Systems since June 2016, Philip has previously held positions as a Quality Assurance In-Process Inspector at Ortho Clinical Diagnostics and QA Inspector at Johnson & Johnson. Philip's career began as a QC Inspector at sanofi-Aventis and included a role as a Buyer at MooneyGeneral Paper Co. Additionally, Philip holds a Bachelor of Arts in Criminology from Rutgers University and a high school diploma from Wardlaw-Hartridge High School in Edison, New Jersey.
This person is not in the org chart
LTS - Lohmann Therapy Systems
LTS Corp is the US-based subsidiary of Lohmann Therapie Systeme whose headquarters are in Andernach, Germany. LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the development of LTS Transdermal and LTS Oral Thin Film technologies, the company also develops innovative microneedle and the ‘active LTS Transdermal’ technology. LTS Microneedles that are long enough to penetrate the outer layer of skin but too short to irritate nerves and blood vessels. They can be used to inject active substances with larger molecules into the skin, an application that is largely pain-free. Microneedles create tiny holes in the outermost layer of skin, which significantly increases the rate at which the active substance is absorbed. LTS is currently researching a number of different microneedles made from different materials and with different gauges, designs and sizes for a wide range of applications.